Genelux   Report issue

For profit Phase 2
Founded: San Diego CA United States (2001)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2008
NCT00794131
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Genelux Corporation | Genelux GmbH